Search - tctmd.com

Displaying 21 - 40 of 106

Sort: Relevancy | Date

SCAI/HRS Consensus Document Covers the Ins and Outs of LAAO

News Daily News

SCAI/HRS Consensus Document Covers the Ins and Outs of LAAO

March 28, 2023

LAAO Tops Oral Anticoagulation for AF in Women and Men: Medicare Analysis

News Daily News

LAAO Tops Oral Anticoagulation for AF in Women and Men: Medicare Analysis

February 24, 2023

Top Structural Heart News of 2022

News Daily News

Top Structural Heart News of 2022

January 06, 2023

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

Presentation TCT 2022

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

Presenter: Khawaja Akhtar

September 19, 2022

Presentation TCT 2022

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

Presentation TCT 2022

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Presenter: Davide Cao

September 18, 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

September 18, 2022

Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI

News Daily News

Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI

Yael L. Maxwell

September 08, 2022

More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

News Conference News ESC 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Michael O'Riordan

August 28, 2022

What’s Going to Be Hot at ESC 2022?

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

August 22, 2022

Stroke, Bleeding Risks Key for Assessing Potential LAAO Benefit

News Daily News

Stroke, Bleeding Risks Key for Assessing Potential LAAO Benefit

August 17, 2022

Real World Outcomes of Left Atrial Appendage Occlusion compared to Novel Oral Anticoagulants - A multicenter electronic health record analysis

Presentation TVT 2022

Real World Outcomes of Left Atrial Appendage Occlusion compared to Novel Oral Anticoagulants - A multicenter electronic health record analysis

Presenter: Arka Chatterjee

June 10, 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

April 05, 2022

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

TCTMD’s Top 10 Most Popular Stories for January 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2022

January 31, 2022

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

October 11, 2021

October 2021 News Roundup

News Opinion CV Team Dispatch

October 2021 News Roundup

October 01, 2021

Amulet IDE: LAA Occluder Performs Well Against Watchman

News Conference News ESC 2021

Amulet IDE: LAA Occluder Performs Well Against Watchman

August 30, 2021

ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting

News Conference News ESC 2021

ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting

August 28, 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

July 28, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.